Biotechnology Assets Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	17	14	18	23	13	21
Market Cap Growth	-27.67%	-22.86%	-19.20%	72.25%	-36.62%	-3.92%
Enterprise Value	18.09	17.59	23.34	29.42	24.05	31.1
Last Close Price	0.22	0.20	0.28	0.40	0.23	0.46
PE Ratio	-	-	-	11.35	-	-
Forward PE	-	2.25	2.25	2.25	2.25	2.25
PS Ratio	4.96	4.61	5.85	43.03	5.08	6.79
PB Ratio	2.44	2.31	3.17	3.93	3.95	5.60
P/TBV Ratio	7.80	6.83	98.12	-	-	-
P/OCF Ratio	-	-	-	478.84	-	-
EV/Sales Ratio	5.27	5.69	7.39	55.37	9.20	10.08
EV/EBITDA Ratio	29.61	28.79	-	4.89	57.42	-
EV/EBIT Ratio	-	-	-	8.29	-	-
Debt / Equity Ratio	0.57	0.57	0.77	1.09	3.03	2.77
Debt / EBITDA Ratio	6.56	6.56	-	1.19	28.00	-
Net Debt / Equity Ratio	0.54	0.54	0.84	1.15	3.25	2.76
Net Debt / EBITDA Ratio	5.47	5.47	-9.68	1.12	26.09	-239.62
Net Debt / FCF Ratio	-221.23	-221.23	-55.59	-307.21	-75.42	-6.79
Asset Turnover	0.22	0.22	0.20	0.03	0.14	0.15
Inventory Turnover	55.61	55.61	-	-	-	27.18
Quick Ratio	1.40	1.40	0.81	1.04	0.88	1.24
Current Ratio	1.40	1.40	0.81	1.04	0.88	1.24
Return on Equity (ROE)	-28.25%	-28.25%	-44.40%	38.72%	-47.33%	-73.66%
Return on Assets (ROA)	-11.90%	-11.90%	-16.47%	14.73%	-8.58%	-10.71%
Return on Invested Capital (ROIC)	-16.38%	-15.49%	-20.91%	18.43%	-11.17%	-14.32%
Return on Capital Employed (ROCE)	-13.69%	-13.69%	-23.31%	25.41%	-11.06%	-15.35%
Earnings Yield	-	-	-	8.81%	-	-
Buyback Yield / Dilution	-	-10.20%	-14.28%	-0.05%	-26.49%	-16.39%
Total Shareholder Return	-	-10.20%	-14.28%	-0.05%	-26.49%	-16.39%